健之佳：8月28日召开董事会会议

Group 1 - The core viewpoint of the article is that Jianzhijia (SH 605266) held its 12th meeting of the 6th Board of Directors on August 28, 2025, to review the agenda including the 2025 semi-annual report and its summary [1] - For the first half of 2025, Jianzhijia's revenue composition was as follows: 90.17% from pharmaceutical retail and services, 5.51% from other businesses, 4.17% from convenience retail, and 0.15% from pharmaceutical wholesale [1]